Further evidence that chronic perindopril treatment maintains neurohormonal suppression but does not lower blood pressure in chronic cardiac failure

British Journal of Clinical Pharmacology

Volumn 44, Issue 1, 1997, Pages 69-76

  MacFadyen, Robert J ^a   Barr, Craig S ^a   Sturrock, Nigel D C ^a   Fenwick, Michael ^a   Struthers, Allan D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

ACE inhibition; Blood pressure response; Chronic cardiac failure; Differential profile or effect; Electrolyte handling; Isotopic renal function studies; Neurohormones; Peridopril

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN I; ANTITHROMBOCYTIC AGENT; ATENOLOL; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ELECTROLYTE; MAGNESIUM; NEUROHORMONE; NITRATE; ORAL ANTIDIABETIC AGENT; PERINDOPRIL; PLACEBO; RADIOISOTOPE; WARFARIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOMYOPATHY; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION TEST; LONG TERM CARE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030789625     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.00618.x     Document Type: Article

References (33)

1. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
2. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-1435.
3. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-691.
4. Ambrosioni E, Borghi C, Magnani B. The effect of the angiotensin converting enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995; 332: 80-85.
5. Zusman R. Angiotensin converting enzyme inhibitors: more different than alike: focus on cardiac performance. Am J Cardiol 1993; 72: 25H-36H.
6. Houghton AR, Cowley AJ. The use of angiotensin converting enzyme inhibitors in heart failure by general practitioners: results of a postal survey. Eur Heart J 1996; 17: 61.
7. Hillis GS, Trent RJ, Winton P, MacLeod AM, Jennings KP. Angiotensin converting enzyme inhibitors in the management of cardiac failure: are we ignoring the evidence? Quart J Med 1995; 89: 145-150.
8. Clarke KW, Gray D, Hampton JR. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J 1994; 71: 584-587.
9. Missouris CG, MacGregor GA. Survey of the use of angiotensin converting enzyme inhibition in the treatment of heart failure in hospital practice. Eur Heart J 1996; 17: 60.
10. Mair FS, Crowley TS, Bundred PE. Prevalence, aetiology and management of heart failure in general practice. Br J Gen Prac 1996; 46: 77-79.
11. MacFadyen RJ, Lees KR, Reid JL. Perindopril: a review of its pharmacokinetics and clinical pharmacology. Drugs 1990; 39(suppl 1): 49-63.
12. Bounhoure JP, Bottineau G, Lechat P, Garnham J, Lapeyre G. Value of perindopril in the treatment of chronic heart failure. Clin Exp Hyp 1989; 11: 575-586.
13. Lees KR, Reid JL, Scott MBG, Hosie J, Herpin D, Santoni JP. Captopril versus perindopril: a double blind study in essential hypertension. J Human Hypertension 1989; 3: 17-22.
14. MacFadyen RJ, Lees KR, Reid JL. Differences in first dose response to ACE inhibitors in congestive cardiac failure - a placebo controlled study. Br Heart J 1991; 66: 206-211.
15. Squire IB, MacFadyen RJ, Lees KR, Reid JL. Differing blood pressure and renin angiotensin system responses to ACE inhibition in heart failure. J Am Coll Cardiol 1994; 23: 376A.
16. MacFadyen RJ. Role of the circulating and tissue based renin angiotensin system in the development of heart failure - implications for therapy. Cardiology 1993; 83: 38-48.
17. Marantz PR, Tobin JN, Wassertheil-Smoller S, et al. The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation 1988; 77: 607-612.
18. Cushman DW, Cheung HS. Spectrophotometric assay and properties of angiotensin converting enzyme in rabbit lung. Biochem Pharmacol 1971; 20: 1637-1648.
19. Cargill RI, Struthers AD, Lipworth BJ. Comparative effects of atrial natriuretic peptide and brain natriuretic peptide on the aldosterone and pressor responses to angiotensin II in man. Clin Sci 1995; 88: 81-86.
20. Motwani JG, Fenwick M, Morton JJ, Struthers AD. Determinants of the initial effects of captopril on BP, GFR and natriuresis in mild to moderate chronic heart failure secondary to coronary artery disease. Am J Cardiol 1994; 73: 1191-1196.
21. Juillerat L, Nussberger J, Menard J, Brunner HR. Determinants of angiotensin II generation during converting enzyme inhibition. Hypertension 1990; 12: 87-92.
22. Kirlin PC, Benedict C, Shelton BJ, et al. Neurohormonal variability in left ventricular dysfunction. Am J Cardiol 1995; 75: 354-359.
23. Lang RM, Di Bianco R, Broderick GT, et al. First dose effects of enalapril 2.5 mg and captopril 6.25 mg in patients with heart failure: a double blind, randomised, multicentre study. Am Heart J 1994; 128: 551-556.
24. Cleland JGF, Dargie HJ, McAlpine H, Ball SG, Robertson JIS, Ford I. Severe hypotension after first dose of enalapril in heart failure. Br Med J 1985; 291: 1309-1312.
25. Hodsman GP, Isles CG, Murray GD, Usherwood TP, Webb DJ, Robertson JIS. Factors related to first dose hypotensive effect of captopril: prediction and treatment. Br Med J 1983; 286: 832-834.
26. Nussberger J, Fleck E, Bahrmann H, Delius W, Schultheiss HP, Brunner HR. Dose related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. Eur Heart J 1994; 15: 113-122.
27. McClay JS, McMurray J, Bridges A, Struthers AD. Practical issues when initiating captopril therapy in chronic heart failure. Eur Heart J 1992; 13: 1521-1527.
28. MacFadyen RJ, Meredith PA, Reid JL. Ester diacid interaction and the response to low dose ACE inhibitors with activation of the renin system in man. J Hypertension 1996; 14: s231.
29. Gottlieb SS, Robinson S, Weir MR, Fisher ML, Krichten CM. Determinants of the renal response to ACE inhibition in patients with congestive heart failure. Am Heart J 1992; 124: 131-136.
30. Packer M, Lee WH, Medina N, Yushak M, Kessler PD. Functional renal insufficiency during long term therapy with captopril and enalapril in severe chronic heart failure. Ann Int Med 1987; 106: 346-354.
31. Giles TD, Katz R, Sullivan J, et al. Short and long acting angiotensin converting enzyme inhibitors: a randomised trial of lisinopril versus captopril in the treatment of congestive heart failure. J Am Coll Cardiol 1989; 13: 1240-1247.
32. Desche P, Antony I, Lerebours G, Violet I, Robert S, Weber C. Acceptability of perindopril in mild to moderate chronic congestive heart failure: results of a long term open study in 320 patients. Am J Cardiol 1993; 71: E61-E68.
33. Annane D, Bellissant E, Pussard E, et al. A placebo controlled, randomized double blind study of intravenous enalaprilat efficacy and safety in acute cardiogenic pulmonary edema. Circulation 1996; 94: I-H.